nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC4—Sorafenib—liver cancer	0.231	0.364	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—liver cancer	0.183	0.289	CbGbCtD
Gadoxetate—ABCC2—Sorafenib—liver cancer	0.137	0.216	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—liver cancer	0.0833	0.131	CbGbCtD
Gadoxetate—ABCC2—bile canaliculus—liver cancer	0.062	0.463	CbGeAlD
Gadoxetate—ABCC3—bile duct—liver cancer	0.0243	0.181	CbGeAlD
Gadoxetate—ABCC2—bile duct—liver cancer	0.0194	0.145	CbGeAlD
Gadoxetate—ABCC2—bile—liver cancer	0.0149	0.111	CbGeAlD
Gadoxetate—ABCC3—gall bladder—liver cancer	0.00517	0.0386	CbGeAlD
Gadoxetate—Gadofosveset trisodium—ALB—liver cancer	0.00284	1	CrCbGaD
Gadoxetate—SLCO1B3—liver—liver cancer	0.00276	0.0206	CbGeAlD
Gadoxetate—Respiratory distress—Sorafenib—liver cancer	0.00263	0.0223	CcSEcCtD
Gadoxetate—Faecalith—Epirubicin—liver cancer	0.00216	0.0183	CcSEcCtD
Gadoxetate—Faecaloma—Epirubicin—liver cancer	0.00216	0.0183	CcSEcCtD
Gadoxetate—Faecaloma—Doxorubicin—liver cancer	0.002	0.017	CcSEcCtD
Gadoxetate—Faecalith—Doxorubicin—liver cancer	0.002	0.017	CcSEcCtD
Gadoxetate—Warmth—Epirubicin—liver cancer	0.00194	0.0165	CcSEcCtD
Gadoxetate—Hypocalcaemia—Sorafenib—liver cancer	0.00182	0.0155	CcSEcCtD
Gadoxetate—Hyperphosphataemia—Epirubicin—liver cancer	0.00181	0.0153	CcSEcCtD
Gadoxetate—Warmth—Doxorubicin—liver cancer	0.00179	0.0152	CcSEcCtD
Gadoxetate—Hyperphosphataemia—Doxorubicin—liver cancer	0.00167	0.0142	CcSEcCtD
Gadoxetate—Blood pressure increased—Sorafenib—liver cancer	0.00167	0.0142	CcSEcCtD
Gadoxetate—SLCO1B1—liver—liver cancer	0.0016	0.0119	CbGeAlD
Gadoxetate—ABCC3—liver—liver cancer	0.00152	0.0113	CbGeAlD
Gadoxetate—Cardiac failure congestive—Sorafenib—liver cancer	0.00134	0.0113	CcSEcCtD
Gadoxetate—Renal failure acute—Sorafenib—liver cancer	0.00131	0.0111	CcSEcCtD
Gadoxetate—ABCC4—liver—liver cancer	0.00125	0.00934	CbGeAlD
Gadoxetate—Bundle branch block—Epirubicin—liver cancer	0.00122	0.0104	CcSEcCtD
Gadoxetate—ABCC2—liver—liver cancer	0.00121	0.00904	CbGeAlD
Gadoxetate—Hypernatraemia—Epirubicin—liver cancer	0.00117	0.00997	CcSEcCtD
Gadoxetate—Venous thrombosis—Epirubicin—liver cancer	0.00114	0.00971	CcSEcCtD
Gadoxetate—Bundle branch block—Doxorubicin—liver cancer	0.00113	0.00961	CcSEcCtD
Gadoxetate—Dehydration—Sorafenib—liver cancer	0.00113	0.00957	CcSEcCtD
Gadoxetate—Hypokalaemia—Sorafenib—liver cancer	0.0011	0.00937	CcSEcCtD
Gadoxetate—Hypernatraemia—Doxorubicin—liver cancer	0.00109	0.00922	CcSEcCtD
Gadoxetate—Venous thrombosis—Doxorubicin—liver cancer	0.00106	0.00898	CcSEcCtD
Gadoxetate—Dysphagia—Sorafenib—liver cancer	0.00105	0.0089	CcSEcCtD
Gadoxetate—Parosmia—Epirubicin—liver cancer	0.000951	0.00808	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Sorafenib—liver cancer	0.00092	0.00782	CcSEcCtD
Gadoxetate—Renal failure—Sorafenib—liver cancer	0.000918	0.0078	CcSEcCtD
Gadoxetate—Myocardial infarction—Sorafenib—liver cancer	0.000915	0.00778	CcSEcCtD
Gadoxetate—Parosmia—Doxorubicin—liver cancer	0.00088	0.00748	CcSEcCtD
Gadoxetate—Connective tissue disorder—Sorafenib—liver cancer	0.000823	0.007	CcSEcCtD
Gadoxetate—Feeling hot—Epirubicin—liver cancer	0.000786	0.00668	CcSEcCtD
Gadoxetate—Necrosis—Epirubicin—liver cancer	0.000786	0.00668	CcSEcCtD
Gadoxetate—Abscess—Epirubicin—liver cancer	0.000779	0.00662	CcSEcCtD
Gadoxetate—Cardiac disorder—Sorafenib—liver cancer	0.000778	0.00661	CcSEcCtD
Gadoxetate—Flushing—Sorafenib—liver cancer	0.000778	0.00661	CcSEcCtD
Gadoxetate—Angiopathy—Sorafenib—liver cancer	0.00076	0.00646	CcSEcCtD
Gadoxetate—Immune system disorder—Sorafenib—liver cancer	0.000757	0.00643	CcSEcCtD
Gadoxetate—Injection site pain—Epirubicin—liver cancer	0.000755	0.00642	CcSEcCtD
Gadoxetate—Mediastinal disorder—Sorafenib—liver cancer	0.000755	0.00642	CcSEcCtD
Gadoxetate—Arrhythmia—Sorafenib—liver cancer	0.000749	0.00636	CcSEcCtD
Gadoxetate—Necrosis—Doxorubicin—liver cancer	0.000727	0.00618	CcSEcCtD
Gadoxetate—Feeling hot—Doxorubicin—liver cancer	0.000727	0.00618	CcSEcCtD
Gadoxetate—Abscess—Doxorubicin—liver cancer	0.000721	0.00613	CcSEcCtD
Gadoxetate—Dysgeusia—Sorafenib—liver cancer	0.000714	0.00607	CcSEcCtD
Gadoxetate—Extravasation—Epirubicin—liver cancer	0.000707	0.00601	CcSEcCtD
Gadoxetate—Injection site pain—Doxorubicin—liver cancer	0.000699	0.00594	CcSEcCtD
Gadoxetate—Cellulitis—Epirubicin—liver cancer	0.000678	0.00576	CcSEcCtD
Gadoxetate—Hypocalcaemia—Epirubicin—liver cancer	0.000674	0.00572	CcSEcCtD
Gadoxetate—Oliguria—Epirubicin—liver cancer	0.000669	0.00569	CcSEcCtD
Gadoxetate—Syncope—Sorafenib—liver cancer	0.000654	0.00556	CcSEcCtD
Gadoxetate—Extravasation—Doxorubicin—liver cancer	0.000654	0.00556	CcSEcCtD
Gadoxetate—Ulcer—Epirubicin—liver cancer	0.000652	0.00554	CcSEcCtD
Gadoxetate—Creatinine increased—Epirubicin—liver cancer	0.000648	0.0055	CcSEcCtD
Gadoxetate—Loss of consciousness—Sorafenib—liver cancer	0.000641	0.00545	CcSEcCtD
Gadoxetate—Cough—Sorafenib—liver cancer	0.000637	0.00541	CcSEcCtD
Gadoxetate—Cellulitis—Doxorubicin—liver cancer	0.000627	0.00533	CcSEcCtD
Gadoxetate—Hypocalcaemia—Doxorubicin—liver cancer	0.000623	0.0053	CcSEcCtD
Gadoxetate—Oliguria—Doxorubicin—liver cancer	0.000619	0.00526	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000617	0.00524	CcSEcCtD
Gadoxetate—Injection site reaction—Epirubicin—liver cancer	0.000613	0.00521	CcSEcCtD
Gadoxetate—Dry mouth—Sorafenib—liver cancer	0.000607	0.00516	CcSEcCtD
Gadoxetate—Ulcer—Doxorubicin—liver cancer	0.000603	0.00513	CcSEcCtD
Gadoxetate—Creatinine increased—Doxorubicin—liver cancer	0.000599	0.00509	CcSEcCtD
Gadoxetate—Salivary hypersecretion—Epirubicin—liver cancer	0.000599	0.00509	CcSEcCtD
Gadoxetate—Anaphylactic shock—Sorafenib—liver cancer	0.000595	0.00506	CcSEcCtD
Gadoxetate—Infection—Sorafenib—liver cancer	0.000591	0.00503	CcSEcCtD
Gadoxetate—Shock—Sorafenib—liver cancer	0.000586	0.00498	CcSEcCtD
Gadoxetate—Fluid retention—Epirubicin—liver cancer	0.000585	0.00497	CcSEcCtD
Gadoxetate—Nervous system disorder—Sorafenib—liver cancer	0.000584	0.00496	CcSEcCtD
Gadoxetate—Blood urea increased—Epirubicin—liver cancer	0.000582	0.00495	CcSEcCtD
Gadoxetate—Skin disorder—Sorafenib—liver cancer	0.000578	0.00491	CcSEcCtD
Gadoxetate—Anorexia—Sorafenib—liver cancer	0.000567	0.00482	CcSEcCtD
Gadoxetate—Injection site reaction—Doxorubicin—liver cancer	0.000567	0.00482	CcSEcCtD
Gadoxetate—Rash maculo-papular—Epirubicin—liver cancer	0.000561	0.00476	CcSEcCtD
Gadoxetate—Salivary hypersecretion—Doxorubicin—liver cancer	0.000554	0.00471	CcSEcCtD
Gadoxetate—Fluid retention—Doxorubicin—liver cancer	0.000542	0.0046	CcSEcCtD
Gadoxetate—Blood urea increased—Doxorubicin—liver cancer	0.000539	0.00458	CcSEcCtD
Gadoxetate—Sepsis—Epirubicin—liver cancer	0.000535	0.00455	CcSEcCtD
Gadoxetate—Dyspnoea—Sorafenib—liver cancer	0.000531	0.00451	CcSEcCtD
Gadoxetate—Phlebitis—Epirubicin—liver cancer	0.00052	0.00442	CcSEcCtD
Gadoxetate—Rash maculo-papular—Doxorubicin—liver cancer	0.000519	0.00441	CcSEcCtD
Gadoxetate—Decreased appetite—Sorafenib—liver cancer	0.000518	0.0044	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Sorafenib—liver cancer	0.000514	0.00437	CcSEcCtD
Gadoxetate—Fatigue—Sorafenib—liver cancer	0.000513	0.00436	CcSEcCtD
Gadoxetate—Constipation—Sorafenib—liver cancer	0.000509	0.00433	CcSEcCtD
Gadoxetate—Sepsis—Doxorubicin—liver cancer	0.000495	0.00421	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Epirubicin—liver cancer	0.000494	0.00419	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Sorafenib—liver cancer	0.000487	0.00414	CcSEcCtD
Gadoxetate—Renal failure acute—Epirubicin—liver cancer	0.000485	0.00412	CcSEcCtD
Gadoxetate—Phlebitis—Doxorubicin—liver cancer	0.000481	0.00409	CcSEcCtD
Gadoxetate—Urticaria—Sorafenib—liver cancer	0.000473	0.00402	CcSEcCtD
Gadoxetate—Abdominal pain—Sorafenib—liver cancer	0.000471	0.004	CcSEcCtD
Gadoxetate—Body temperature increased—Sorafenib—liver cancer	0.000471	0.004	CcSEcCtD
Gadoxetate—Renal impairment—Epirubicin—liver cancer	0.00047	0.004	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Epirubicin—liver cancer	0.000463	0.00393	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Epirubicin—liver cancer	0.000457	0.00388	CcSEcCtD
Gadoxetate—Cardiac failure congestive—Doxorubicin—liver cancer	0.000457	0.00388	CcSEcCtD
Gadoxetate—Renal failure acute—Doxorubicin—liver cancer	0.000449	0.00381	CcSEcCtD
Gadoxetate—Hypersensitivity—Sorafenib—liver cancer	0.000439	0.00373	CcSEcCtD
Gadoxetate—Renal impairment—Doxorubicin—liver cancer	0.000435	0.0037	CcSEcCtD
Gadoxetate—Face oedema—Epirubicin—liver cancer	0.000432	0.00367	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000428	0.00364	CcSEcCtD
Gadoxetate—Asthenia—Sorafenib—liver cancer	0.000427	0.00363	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—liver cancer	0.000423	0.00359	CcSEcCtD
Gadoxetate—Pruritus—Sorafenib—liver cancer	0.000421	0.00358	CcSEcCtD
Gadoxetate—Blood creatinine increased—Epirubicin—liver cancer	0.000419	0.00356	CcSEcCtD
Gadoxetate—Dehydration—Epirubicin—liver cancer	0.000416	0.00354	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—liver cancer	0.000407	0.00346	CcSEcCtD
Gadoxetate—Diarrhoea—Sorafenib—liver cancer	0.000407	0.00346	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—liver cancer	0.0004	0.0034	CcSEcCtD
Gadoxetate—Dizziness—Sorafenib—liver cancer	0.000394	0.00335	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—liver cancer	0.000389	0.00331	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—liver cancer	0.000388	0.0033	CcSEcCtD
Gadoxetate—Dysphagia—Epirubicin—liver cancer	0.000387	0.00329	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—liver cancer	0.000385	0.00327	CcSEcCtD
Gadoxetate—Vomiting—Sorafenib—liver cancer	0.000379	0.00322	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—liver cancer	0.000377	0.0032	CcSEcCtD
Gadoxetate—Rash—Sorafenib—liver cancer	0.000375	0.00319	CcSEcCtD
Gadoxetate—Dermatitis—Sorafenib—liver cancer	0.000375	0.00319	CcSEcCtD
Gadoxetate—Headache—Sorafenib—liver cancer	0.000373	0.00317	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—liver cancer	0.000372	0.00316	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—liver cancer	0.00036	0.00306	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—liver cancer	0.000358	0.00304	CcSEcCtD
Gadoxetate—Nausea—Sorafenib—liver cancer	0.000354	0.003	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—liver cancer	0.000344	0.00293	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—liver cancer	0.000339	0.00288	CcSEcCtD
Gadoxetate—Conjunctivitis—Epirubicin—liver cancer	0.000335	0.00285	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—liver cancer	0.000314	0.00267	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—liver cancer	0.00031	0.00264	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—liver cancer	0.00031	0.00264	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—liver cancer	0.000308	0.00262	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—liver cancer	0.000304	0.00259	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—liver cancer	0.000287	0.00244	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—liver cancer	0.000287	0.00244	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—liver cancer	0.000287	0.00244	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—liver cancer	0.000285	0.00242	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—liver cancer	0.000282	0.00239	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—liver cancer	0.000281	0.00239	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—liver cancer	0.00028	0.00238	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—liver cancer	0.000279	0.00237	CcSEcCtD
Gadoxetate—Chills—Epirubicin—liver cancer	0.000278	0.00236	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—liver cancer	0.000277	0.00235	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—liver cancer	0.000266	0.00226	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—liver cancer	0.000266	0.00226	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—liver cancer	0.000266	0.00226	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—liver cancer	0.000264	0.00224	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—liver cancer	0.000261	0.00222	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—liver cancer	0.00026	0.00221	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—liver cancer	0.000259	0.0022	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—liver cancer	0.000258	0.00219	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—liver cancer	0.000257	0.00218	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—liver cancer	0.000256	0.00218	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—liver cancer	0.000254	0.00216	CcSEcCtD
Gadoxetate—Ill-defined disorder—Epirubicin—liver cancer	0.00025	0.00213	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—liver cancer	0.000248	0.00211	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—liver cancer	0.000246	0.00209	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—liver cancer	0.000244	0.00208	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—liver cancer	0.000243	0.00207	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—liver cancer	0.000242	0.00206	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—liver cancer	0.000242	0.00205	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—liver cancer	0.000241	0.00205	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—liver cancer	0.000238	0.00202	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—liver cancer	0.000237	0.00201	CcSEcCtD
Gadoxetate—Cough—Epirubicin—liver cancer	0.000235	0.002	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—liver cancer	0.000235	0.002	CcSEcCtD
Gadoxetate—Convulsion—Epirubicin—liver cancer	0.000234	0.00198	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—liver cancer	0.000231	0.00197	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—liver cancer	0.00023	0.00195	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—liver cancer	0.000229	0.00195	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—liver cancer	0.000229	0.00194	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000228	0.00194	CcSEcCtD
Gadoxetate—Discomfort—Epirubicin—liver cancer	0.000227	0.00193	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—liver cancer	0.000225	0.00191	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000225	0.00203	CbGpPWpGaD
Gadoxetate—Dry mouth—Epirubicin—liver cancer	0.000224	0.00191	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—liver cancer	0.000224	0.0019	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—liver cancer	0.000224	0.0019	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—HGF—liver cancer	0.000223	0.00201	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GSTM1—liver cancer	0.000223	0.00201	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000222	0.00201	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SERPINE1—liver cancer	0.000222	0.002	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—ALB—liver cancer	0.000221	0.002	CbGpPWpGaD
Gadoxetate—Palpitations—Doxorubicin—liver cancer	0.00022	0.00187	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—liver cancer	0.00022	0.00187	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—liver cancer	0.00022	0.00187	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—liver cancer	0.000219	0.00186	CcSEcCtD
Gadoxetate—Infection—Epirubicin—liver cancer	0.000219	0.00186	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—liver cancer	0.000218	0.00185	CcSEcCtD
Gadoxetate—Shock—Epirubicin—liver cancer	0.000216	0.00184	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—liver cancer	0.000216	0.00184	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—liver cancer	0.000216	0.00183	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000216	0.00195	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000216	0.00195	CbGpPWpGaD
Gadoxetate—Tachycardia—Epirubicin—liver cancer	0.000215	0.00182	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000214	0.00194	CbGpPWpGaD
Gadoxetate—Skin disorder—Epirubicin—liver cancer	0.000214	0.00182	CcSEcCtD
Gadoxetate—Hyperhidrosis—Epirubicin—liver cancer	0.000213	0.00181	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000213	0.00192	CbGpPWpGaD
Gadoxetate—Chest pain—Doxorubicin—liver cancer	0.000212	0.0018	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—liver cancer	0.000212	0.0018	CcSEcCtD
Gadoxetate—ABCC4—Hemostasis—ANXA2—liver cancer	0.000211	0.00191	CbGpPWpGaD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000211	0.00179	CcSEcCtD
Gadoxetate—Discomfort—Doxorubicin—liver cancer	0.00021	0.00178	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—liver cancer	0.00021	0.00178	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—liver cancer	0.000208	0.00176	CcSEcCtD
Gadoxetate—Hypotension—Epirubicin—liver cancer	0.000206	0.00175	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—GSTP1—liver cancer	0.000205	0.00185	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000204	0.00184	CbGpPWpGaD
Gadoxetate—Anaphylactic shock—Doxorubicin—liver cancer	0.000204	0.00173	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—liver cancer	0.000204	0.00173	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000203	0.00183	CbGpPWpGaD
Gadoxetate—Infection—Doxorubicin—liver cancer	0.000202	0.00172	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—HMOX1—liver cancer	0.000202	0.00182	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000201	0.00181	CbGpPWpGaD
Gadoxetate—Shock—Doxorubicin—liver cancer	0.0002	0.0017	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.0002	0.00181	CbGpPWpGaD
Gadoxetate—Nervous system disorder—Doxorubicin—liver cancer	0.0002	0.0017	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—liver cancer	0.000199	0.00169	CcSEcCtD
Gadoxetate—Skin disorder—Doxorubicin—liver cancer	0.000198	0.00168	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—liver cancer	0.000198	0.00168	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—liver cancer	0.000197	0.00167	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—liver cancer	0.000196	0.00167	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000194	0.00176	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000194	0.00176	CbGpPWpGaD
Gadoxetate—Anorexia—Doxorubicin—liver cancer	0.000194	0.00165	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000193	0.00175	CbGpPWpGaD
Gadoxetate—Decreased appetite—Epirubicin—liver cancer	0.000191	0.00163	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000191	0.00172	CbGpPWpGaD
Gadoxetate—Hypotension—Doxorubicin—liver cancer	0.00019	0.00162	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—liver cancer	0.00019	0.00161	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—liver cancer	0.00019	0.00161	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—liver cancer	0.000188	0.0016	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—GSTM1—liver cancer	0.000188	0.0017	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—HGF—liver cancer	0.000188	0.0017	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000184	0.00166	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000183	0.00165	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000183	0.00165	CbGpPWpGaD
Gadoxetate—Paraesthesia—Doxorubicin—liver cancer	0.000183	0.00155	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—liver cancer	0.000181	0.00154	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—liver cancer	0.000181	0.00154	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Epirubicin—liver cancer	0.00018	0.00153	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PRKCE—liver cancer	0.000179	0.00162	CbGpPWpGaD
Gadoxetate—Decreased appetite—Doxorubicin—liver cancer	0.000177	0.0015	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000176	0.00149	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—liver cancer	0.000176	0.00149	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—liver cancer	0.000175	0.00149	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—liver cancer	0.000174	0.00148	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—liver cancer	0.000174	0.00148	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—liver cancer	0.000174	0.00148	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000173	0.00156	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IGF2—liver cancer	0.000169	0.00153	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000169	0.00152	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Doxorubicin—liver cancer	0.000168	0.00143	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000166	0.00141	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000164	0.00148	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—UGDH—liver cancer	0.000163	0.00148	CbGpPWpGaD
Gadoxetate—Hypersensitivity—Epirubicin—liver cancer	0.000162	0.00138	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—liver cancer	0.000162	0.00137	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—liver cancer	0.000161	0.00137	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—liver cancer	0.000161	0.00137	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000161	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—liver cancer	0.00016	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—HGF—liver cancer	0.00016	0.00145	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000158	0.00143	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—CSF2—liver cancer	0.000158	0.00143	CbGpPWpGaD
Gadoxetate—Asthenia—Epirubicin—liver cancer	0.000158	0.00134	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—liver cancer	0.000156	0.00132	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000154	0.00139	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000154	0.00139	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—EPT1—liver cancer	0.000154	0.00139	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—liver cancer	0.000153	0.00138	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000151	0.00136	CbGpPWpGaD
Gadoxetate—Diarrhoea—Epirubicin—liver cancer	0.000151	0.00128	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—liver cancer	0.00015	0.00127	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000149	0.00135	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000148	0.00134	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—UGDH—liver cancer	0.000147	0.00133	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—TGFB1—liver cancer	0.000147	0.00133	CbGpPWpGaD
Gadoxetate—Asthenia—Doxorubicin—liver cancer	0.000146	0.00124	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000146	0.00132	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TAT—liver cancer	0.000146	0.00132	CbGpPWpGaD
Gadoxetate—Dizziness—Epirubicin—liver cancer	0.000145	0.00124	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000145	0.00131	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000145	0.00131	CbGpPWpGaD
Gadoxetate—Pruritus—Doxorubicin—liver cancer	0.000144	0.00122	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000144	0.0013	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000143	0.00129	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—liver cancer	0.00014	0.00127	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINA1—liver cancer	0.00014	0.00126	CbGpPWpGaD
Gadoxetate—Vomiting—Epirubicin—liver cancer	0.00014	0.00119	CcSEcCtD
Gadoxetate—Diarrhoea—Doxorubicin—liver cancer	0.000139	0.00118	CcSEcCtD
Gadoxetate—Rash—Epirubicin—liver cancer	0.000139	0.00118	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—EPT1—liver cancer	0.000139	0.00125	CbGpPWpGaD
Gadoxetate—Dermatitis—Epirubicin—liver cancer	0.000139	0.00118	CcSEcCtD
Gadoxetate—Headache—Epirubicin—liver cancer	0.000138	0.00117	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000137	0.00124	CbGpPWpGaD
Gadoxetate—Dizziness—Doxorubicin—liver cancer	0.000135	0.00114	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—TAT—liver cancer	0.000131	0.00119	CbGpPWpGaD
Gadoxetate—Nausea—Epirubicin—liver cancer	0.000131	0.00111	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—liver cancer	0.000129	0.0011	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000129	0.00117	CbGpPWpGaD
Gadoxetate—Rash—Doxorubicin—liver cancer	0.000128	0.00109	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—liver cancer	0.000128	0.00109	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—MAPK14—liver cancer	0.000128	0.00116	CbGpPWpGaD
Gadoxetate—Headache—Doxorubicin—liver cancer	0.000128	0.00108	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—F2—liver cancer	0.000124	0.00112	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—liver cancer	0.000121	0.00103	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—liver cancer	0.000119	0.00107	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—liver cancer	0.000118	0.00106	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00011	0.000995	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—UGDH—liver cancer	0.00011	0.000992	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000107	0.000968	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—ALB—liver cancer	0.000107	0.000964	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	0.000104	0.000943	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA1—liver cancer	0.000104	0.000941	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000104	0.000938	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	0.000103	0.000933	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—EPT1—liver cancer	0.000103	0.000932	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—ALB—liver cancer	0.000103	0.000931	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CPT1B—liver cancer	9.9e-05	0.000894	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GLUL—liver cancer	9.9e-05	0.000894	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TAT—liver cancer	9.78e-05	0.000884	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.67e-05	0.000874	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—liver cancer	9.66e-05	0.000873	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	9.62e-05	0.000869	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NR1H4—liver cancer	9.55e-05	0.000862	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—liver cancer	9.53e-05	0.000861	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTA3—liver cancer	9.38e-05	0.000848	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—CYCS—liver cancer	9.37e-05	0.000847	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—RAF1—liver cancer	9.32e-05	0.000842	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PRKCE—liver cancer	9.22e-05	0.000833	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	9.1e-05	0.000822	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—liver cancer	9.08e-05	0.000821	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—HMOX1—liver cancer	9.03e-05	0.000816	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GLUL—liver cancer	8.93e-05	0.000807	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CPT1B—liver cancer	8.93e-05	0.000807	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—CYCS—liver cancer	8.81e-05	0.000796	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ABL1—liver cancer	8.77e-05	0.000792	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IGF2—liver cancer	8.73e-05	0.000789	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NR1H4—liver cancer	8.61e-05	0.000778	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTA4—liver cancer	8.58e-05	0.000775	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTA3—liver cancer	8.47e-05	0.000765	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8.39e-05	0.000758	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTA2—liver cancer	8.36e-05	0.000756	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—liver cancer	8.36e-05	0.000755	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HGF—liver cancer	8.25e-05	0.000745	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CSF2—liver cancer	8.15e-05	0.000737	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—HMOX1—liver cancer	8.15e-05	0.000736	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTA1—liver cancer	8.07e-05	0.000729	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NAT2—liver cancer	7.98e-05	0.000721	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTA4—liver cancer	7.74e-05	0.0007	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.67e-05	0.000693	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—HMOX1—liver cancer	7.66e-05	0.000692	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—liver cancer	7.66e-05	0.000692	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALDOB—liver cancer	7.65e-05	0.000691	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.57e-05	0.000684	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTA2—liver cancer	7.55e-05	0.000682	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—CYCS—liver cancer	7.43e-05	0.000671	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CRABP1—liver cancer	7.3e-05	0.000659	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—PPARA—liver cancer	7.3e-05	0.000659	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTA1—liver cancer	7.28e-05	0.000658	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	7.2e-05	0.000651	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NAT2—liver cancer	7.2e-05	0.00065	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—ALB—liver cancer	7.17e-05	0.000648	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—liver cancer	7.1e-05	0.000642	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—CYCS—liver cancer	6.98e-05	0.00063	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.92e-05	0.000625	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALDOB—liver cancer	6.9e-05	0.000624	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CPT1B—liver cancer	6.65e-05	0.000601	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GLUL—liver cancer	6.65e-05	0.000601	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MAPK14—liver cancer	6.6e-05	0.000596	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CRABP1—liver cancer	6.58e-05	0.000595	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—PPARA—liver cancer	6.58e-05	0.000595	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.57e-05	0.000594	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—liver cancer	6.52e-05	0.000589	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—HMOX1—liver cancer	6.46e-05	0.000584	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NR1H4—liver cancer	6.41e-05	0.000579	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—F2—liver cancer	6.4e-05	0.000578	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HPGDS—liver cancer	6.38e-05	0.000576	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.34e-05	0.000573	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA3—liver cancer	6.3e-05	0.00057	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—PPARA—liver cancer	6.19e-05	0.000559	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—liver cancer	6.12e-05	0.000553	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—HMOX1—liver cancer	6.07e-05	0.000548	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.93e-05	0.000536	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.78e-05	0.000522	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA4—liver cancer	5.77e-05	0.000521	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HPGDS—liver cancer	5.76e-05	0.00052	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.72e-05	0.000517	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.7e-05	0.000515	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PSMD10—liver cancer	5.69e-05	0.000514	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PSMA4—liver cancer	5.69e-05	0.000514	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.64e-05	0.000509	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA2—liver cancer	5.62e-05	0.000508	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	5.55e-05	0.000501	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GOT2—liver cancer	5.53e-05	0.0005	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ALB—liver cancer	5.42e-05	0.00049	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTA1—liver cancer	5.42e-05	0.00049	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—liver cancer	5.38e-05	0.000486	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NAT2—liver cancer	5.36e-05	0.000484	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SERPINE1—liver cancer	5.32e-05	0.000481	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ALB—liver cancer	5.31e-05	0.00048	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—PPARA—liver cancer	5.22e-05	0.000471	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.21e-05	0.000471	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2E1—liver cancer	5.2e-05	0.00047	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.15e-05	0.000466	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.14e-05	0.000465	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALDOB—liver cancer	5.14e-05	0.000464	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PSMA4—liver cancer	5.13e-05	0.000463	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PSMD10—liver cancer	5.13e-05	0.000463	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	5.03e-05	0.000455	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GOT2—liver cancer	4.99e-05	0.000451	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—RAF1—liver cancer	4.9e-05	0.000443	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CRABP1—liver cancer	4.9e-05	0.000443	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—PPARA—liver cancer	4.9e-05	0.000443	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ALB—liver cancer	4.89e-05	0.000442	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYCS—liver cancer	4.87e-05	0.00044	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RAF1—liver cancer	4.81e-05	0.000434	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GGT1—liver cancer	4.77e-05	0.000431	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GOT1—liver cancer	4.77e-05	0.000431	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2E1—liver cancer	4.69e-05	0.000424	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—liver cancer	4.69e-05	0.000424	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ALB—liver cancer	4.6e-05	0.000416	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.54e-05	0.00041	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—liver cancer	4.53e-05	0.000409	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—RAF1—liver cancer	4.42e-05	0.0004	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.41e-05	0.000399	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYCS—liver cancer	4.39e-05	0.000397	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—liver cancer	4.31e-05	0.000389	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GGT1—liver cancer	4.31e-05	0.000389	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GOT1—liver cancer	4.31e-05	0.000389	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTP1—liver cancer	4.29e-05	0.000387	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HPGDS—liver cancer	4.29e-05	0.000387	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.26e-05	0.000385	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—HMOX1—liver cancer	4.23e-05	0.000382	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—RAF1—liver cancer	4.16e-05	0.000376	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTM1—liver cancer	3.94e-05	0.000356	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.88e-05	0.000351	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ALB—liver cancer	3.88e-05	0.00035	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTP1—liver cancer	3.87e-05	0.00035	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.83e-05	0.000346	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PSMD10—liver cancer	3.82e-05	0.000345	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PSMA4—liver cancer	3.82e-05	0.000345	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—HMOX1—liver cancer	3.82e-05	0.000345	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP1A1—liver cancer	3.74e-05	0.000337	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GOT2—liver cancer	3.72e-05	0.000336	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—liver cancer	3.66e-05	0.000331	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	3.64e-05	0.000329	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTM1—liver cancer	3.56e-05	0.000321	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—RAF1—liver cancer	3.51e-05	0.000317	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2E1—liver cancer	3.49e-05	0.000316	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—MTHFR—liver cancer	3.48e-05	0.000315	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARA—liver cancer	3.42e-05	0.000309	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.38e-05	0.000306	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP1A1—liver cancer	3.37e-05	0.000305	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—liver cancer	3.36e-05	0.000304	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	3.29e-05	0.000298	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYCS—liver cancer	3.27e-05	0.000295	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GGT1—liver cancer	3.21e-05	0.00029	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GOT1—liver cancer	3.21e-05	0.00029	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—MTHFR—liver cancer	3.14e-05	0.000284	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—liver cancer	3.11e-05	0.000281	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARA—liver cancer	3.08e-05	0.000279	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	3.07e-05	0.000277	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—liver cancer	2.93e-05	0.000264	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTP1—liver cancer	2.88e-05	0.00026	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—liver cancer	2.86e-05	0.000258	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HMOX1—liver cancer	2.84e-05	0.000257	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—liver cancer	2.82e-05	0.000255	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.77e-05	0.00025	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—liver cancer	2.77e-05	0.00025	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTM1—liver cancer	2.65e-05	0.000239	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—liver cancer	2.65e-05	0.000239	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—liver cancer	2.64e-05	0.000239	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—liver cancer	2.57e-05	0.000232	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—liver cancer	2.55e-05	0.00023	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ALB—liver cancer	2.54e-05	0.000229	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP1A1—liver cancer	2.51e-05	0.000227	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—MTHFR—liver cancer	2.34e-05	0.000211	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—liver cancer	2.34e-05	0.000211	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—liver cancer	2.32e-05	0.00021	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARA—liver cancer	2.3e-05	0.000207	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ALB—liver cancer	2.29e-05	0.000207	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—liver cancer	2.24e-05	0.000203	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.06e-05	0.000186	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—liver cancer	2.02e-05	0.000183	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—liver cancer	1.97e-05	0.000178	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—liver cancer	1.9e-05	0.000171	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—liver cancer	1.73e-05	0.000156	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ALB—liver cancer	1.71e-05	0.000154	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—liver cancer	1.51e-05	0.000136	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—liver cancer	1.37e-05	0.000123	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—liver cancer	1.23e-05	0.000111	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—liver cancer	1.12e-05	0.000101	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—liver cancer	1.01e-05	9.1e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—liver cancer	9.18e-06	8.3e-05	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—liver cancer	7.5e-06	6.78e-05	CbGpPWpGaD
